These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1785669)

  • 21. Efficacy and tolerability of recombinant human erythropoietin treatment in pre-dialysis patients: results of a multicenter study.
    Albertazzi A; Di Liberato L; Daniele F; Battistel V; Colombi L
    Int J Artif Organs; 1998 Jan; 21(1):12-8. PubMed ID: 9554820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of anemia of nephrotic syndrome with recombinant erythropoietin.
    Gansevoort RT; Vaziri ND; de Jong PE
    Am J Kidney Dis; 1996 Aug; 28(2):274-7. PubMed ID: 8768925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo.
    Cascinu S; Fedeli A; Del Ferro E; Luzi Fedeli S; Catalano G
    J Clin Oncol; 1994 May; 12(5):1058-62. PubMed ID: 8164030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoietin deficiency causes anemia in nephrotic children with normal kidney function.
    Feinstein S; Becker-Cohen R; Algur N; Raveh D; Shalev H; Shvil Y; Frishberg Y
    Am J Kidney Dis; 2001 Apr; 37(4):736-42. PubMed ID: 11273873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant human erythropoietin may correct erythropoietin-deficient hyporegenerative anaemia in children given cardiac transplantation.
    Locatelli F; Zecca M; Mamprin F; Gamba A; Giorgiani G; De Stefano P
    Br J Haematol; 1994 Nov; 88(3):623-5. PubMed ID: 7819078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: an in vitro study.
    Maggioni D; Nicolini G; Chiorazzi A; Meregalli C; Cavaletti G; Tredici G
    J Neurosci Res; 2010 Nov; 88(14):3171-9. PubMed ID: 20722073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is recombinant human erythropoietin (rh-epo) more than just a treatment of anemia in cancer and chemotherapy?
    Taylor SK
    Med Hypotheses; 2003 Jan; 60(1):89-93. PubMed ID: 12450771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current and potential applications for erythropoietin.
    Pedrazzini A
    Acta Haematol; 1992; 87 Suppl 1():2-3. PubMed ID: 1574962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythropoietin ameliorates anemia of cisplatin induced acute renal failure.
    Baldwin MD; Zhou XJ; Ing TS; Vaziri ND
    ASAIO J; 1998; 44(1):44-7. PubMed ID: 9466500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant human erythropoietin in the treatment of the anaemia of cancer.
    Abels RI
    Acta Haematol; 1992; 87 Suppl 1():4-11. PubMed ID: 1574966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum erythropoietin in children with iron deficiency anemia.
    Cetin M; Gürgey A; Gümrük F; Altay C
    Turk J Pediatr; 1997; 39(4):459-64. PubMed ID: 9433147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
    Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Erythropoietin: biochemical characteristics, biologic effects, indications and results of use in hematology].
    Marmont AM
    Tumori; 1997; 83(4 Suppl 2):S3-15. PubMed ID: 9487378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyporegenerative anemia associated with Rh hemolytic disease: treatment failure of recombinant erythropoietin.
    Pessler F; Hart D
    J Pediatr Hematol Oncol; 2002 Nov; 24(8):689-93. PubMed ID: 12439047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the efficacy of two dosages and schedules of human recombinant erythropoietin in the prevention and correction of cisplatin-induced anemia in cancer patients.
    Mantovani G; Ghiani M; Curreli L; Maccio A; Massa D; Succu G; Lai P; Massa E; Mudu MC; Astara G
    Oncol Rep; 1999; 6(2):421-6. PubMed ID: 10023014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of recombinant human erythropoietin on autologous blood pre-donation in open heart surgery].
    Ono Y; Narita J; Takahashi S; Sawada M; Iwabuchi S; Tani A; Iwabuchi S; Shuto K; Fukui K; Kako N
    Kyobu Geka; 1991 Aug; 44(9):728-31. PubMed ID: 1956131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of the anemia of aplastic anemia patients with recombinant human erythropoietin in combination with granulocyte colony-stimulating factor: a multicenter randomized controlled study. Multicenter Study Group.
    Bessho M; Hirashima K; Asano S; Ikeda Y; Ogawa N; Tomonaga M; Toyama K; Nakahata T; Nomura T; Mizoguchi H; Yoshida Y; Niitsu Y; Kohgo Y
    Eur J Haematol; 1997 Apr; 58(4):265-72. PubMed ID: 9186538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth.
    Bianchi R; Gilardini A; Rodriguez-Menendez V; Oggioni N; Canta A; Colombo T; De Michele G; Martone S; Sfacteria A; Piedemonte G; Grasso G; Beccaglia P; Ghezzi P; D'Incalci M; Lauria G; Cavaletti G
    Eur J Cancer; 2007 Mar; 43(4):710-7. PubMed ID: 17251006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.